Distinct localization and function of 1,4,5IP3 receptor subtypes and the 1,3,4,5IP4 receptor GAP1(IP4BP) in highly purified human platelet membranes

Blood

Volumn 95, Issue 11, 2000, Pages 3412-3422

  El Daher, Samer S ^b   Patel, Yatin ^b   Siddiqua, Ashia ^b   Hassock, Sheila ^b   Edmunds, Scott ^b   Maddison, Benjamin ^b   Patel, Geeta ^b   Goulding, David ^b   Lupu, Florea ^b   Wojcikiewicz, Richard J H ^b   Authi, Kalwant S ^a  

^a THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCIUM ION; INOSITOL TRISPHOSPHATE; RECEPTOR SUBTYPE;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGOLD STAINING; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

EID: 0034210271     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3412     Document Type: Article

References (71)

1. 2+ homeostasis in human platelets. In: von Bruchhausen, Walter U, eds. Handbook of Experimental Pharmacology. Vol 126. Berlin: Springer-Verlag; 1997:325-370.
2. Putney JW Jr. Capacitative calcium entry revisited. Cell Calcium. 1990;11:611-624.
3. 2+ entry. Biochem J. 1995;312:1-11.
4. 2+ influx. Nature. 1993; 364:809-814.
5. Bird GSJ, Putney JW. Inhibition of thapsigargin-induced calcium entry by microinjected guanine nucleotide analogues: evidence for the involvement of a small G-protein in capacitative calcium entry. J Biol Chem. 1993;268:21,486-21,488.
6. Vostal JG, Jackson WL, Shulman NR. Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J Biol Chem. 1992;266:16,911-16,916.
7. 2+ entry by inositol phosphates - a possible mechanism. FEBS Lett. 1990;263:5-9.
8. 2T purinoceptors in human platelets. J Biol Chem. 1996;271:2879-2881.
9. 2+ release from platelet plasma membrane vesicles. Biochim Biophys Res Commun. 1988;150:1021-1026.
10. 2+ permeable channel. Nature. 1992;326:301-304.
11. IP4BP. Biochem J. 1996;315:1027-1034.
12. 4 binding protein as a member of the GAP 1 family. Nature. 1995;376: 527-530.
13. m. J Biol Chem. 1996;271:18,838-18,842.
14. Hammonds-Odie L, Jackson TR, Profit AA, et al. Identification and cloning of centaurin-α. J Biol Chem. 1996;271:18,859-18,868.
15. 4 receptor. Biochem J. 1998;331:947-952.
16. Furuichi T, Kohda K, Miyawaki A, Mikoshiba K. Intracellular channels. Curr Opin Neurobiol. 1994; 4:294-303.
17. 3 receptor and intracellular calcium signalling. Curr Opin Neurobiol. 1997;7: 339-345.
18. 3. J Biol Chem. 1994; 269:28,613-28,619.
19. Marshall ICB, Taylor CW. Regulation of inositol 1,4,5-trisphosphate receptors. J Exp Biol. 1993; 184:161-182.
20. 3 receptor from platelets and comparison with receptor subtypes in other normal and transformed blood cells. Biochem J. 1995;312: 499-503.
21. 2+ release trom platelet internal membranes is regulated by differential phosphorylation. Biochemistry. 1996;35:6865-6871.
22. Quinton TM, Dean WL. Multiple inositol 1,4,5-trisphosphate receptor isoforms are present in platelets. Biochim Biophys Res Commun. 1996; 224:740-746.
23. El-Daher SS, Eigenthaler M, Walter U, et al. Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes. Thromb Haemost. 1996;76:1063-1071.
24. Wojcikiewicz RJH. Type I, II and III inositol 1,4,5-trisphosphate receptor isoforms are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J Biol Chem. 1995;270:11,678-11,683.
25. 3 binding site on platelet membranes isolated by high voltage free flow electrophoresis. FEBS Lett. 1992;298:173-176.
26. 2+ ATPase in human platelets. Biochem J. 1995;306:837-842.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head by bacteriophage T4. Nature. 1970;227:680-685.
28. Cheng H-C. Kemp BE, Pearson RB, et al. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem. 1986;261:989-992.
29. Clemetson KJ. Clinical aspects of platelet function. In: Watson SP, Authi KS, eds, Platelets: A Practical Approach. Oxford, UK: IRL Press; 1996: 299-318.
30. Tokuyasu KT. A technique for ultracryotomy of cell suspensions and tissues. J Cell Biol. 1973;57: 551-565.
31. van Genderen IL, van Meer G, Slot JW, Geuze HJ, Voorhout WF. Subcellular localisation of Forssman glycolipid in epithelial MDCK cells by immuno-electronmicroscopy after freeze-substitution. J Cell Biol. 1991;115:1009-1019.
32. Menashi S, Weintroub H, Crawford N. Characterization of human platelet surface and intracellular membranes isolated by free flow electrophoresis. J Biol Chem. 1981;256:4095-4101.
33. Crawford N, Authi KS, Hack N. Isolation and characterisation of platelet membranes prepared by free flow electrophoresis. Methods Enzymol. 1992;215:5-20.
34. Hack N, Crawford N. Two-dimensional polyacrylamide gel electrophoresis of the proteins and glycoproteins of purified human platelet surface and intracellular membranes. Biochem J. 1984;222: 235-246.
35. Cullen PJ, Patel Y, Kakkar VV, Irvine RF, Authi KS. Specific binding sites for inositol 1,3,4,5-tetrakisphosphate are located predominantly in the plasma membrane of human platelets. Biochem J. 1994;298:739-742.
36. Halbrugge M, Friedrich C, Eigenthaler M, Schanzenbacher P, Walter U. Stoichiometric and reversible phosphorylation of a 46 kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem. 1990; 265:3088-3093.
37. Kuno M, Gardner P. Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature. 1987;355:356-358.
38. 3 receptor: localisation to plasma membrane of T cells and co-capping with the T cell receptor. Science. 1992;257:815-818.
39. Fujimoto T, Nakade S, Miyawake A, Mikoshiba K, Ogawa K. Localisation of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol. 1992;119:1507-1513.
40. Cunningham AM, Ryugo DK, Sharp AH, Reed RR, Snyder SH, Ronnet GV. Neuronal inositol 1,4,5-trisphosphate receptor localised to the plasma membrane of olfactory cilia. Neuroscience. 1993;57:339-352.
41. Bush KT, Stuart RO, Li S-H, et al. Epithelial inositol 1,4,5-trisphosphate receptors. J Biol Chem. 1994;269:23,694-23,699.
42. Khan AA, Soloski MJ, Sharp AH, et al. Lymphocyte apoptosis: mediated by increased type 3 inositol 1,4,5-trisphosphate receptor. Science. 1996; 273:503-507.
43. 2+ signal of Xenopus oocytes. Am J Physiol. 1996;270: C1255-C1261.
44. 3 receptor channel stays open in the presence of increased calcium. Nature. 1998;396:81-84.
45. 2+ entry. Cell Calcium. 1997;21:257-261.
46. Authi KS, Crawford N. Inositol (1,4,5) trisphosphate induced release of sequestered calcium from highly purified human platelet intracellular membranes. Biochem J. 1985;230:247-253.
47. 2+ release do not involve direct interaction of inositol 1,3,4,5-tetrakisphosphate with inositol trisphosphate binding sites. Biochem J. 1996;314:811-816.
48. Wilcox RA, Challiss RAJ, Liu C, Potter BVL, Nahorski SR. Inositol 1,3,4,5-tetrakisphosphate induces calcium mobilisation via the inositol 1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells. Mol Pharmacol. 1993;44:810-817.
49. 2+ entry into acinar cells by a non-phosphorylatable inositol trisphosphate. Nature. 1991;352:162-165.
50. + channels. Nature. 1987;330:653-655.
51. 2+ in mouse lacrylmal acinar cells. FEBS Lett. 1989;251:43-48.
52. - current in isolated mouse lacrimal cells. Biochem J. 1992; 283:27-30.
53. 2+ influx in voltage-clamped ras-transformed NIH/3T3 fibroblasts. J Biol Chem. 1993;268:19,403-19,410.
54. 2+ influx. Biochemistry. 1998;37:9776-9783.
55. IP4BP PH domain directing plasma membrane targeting. Curr Biol. 1997;7:1007-1010.
56. 2+ release. Cell. 1997;89:973-980.
57. 3 receptors and store operated Htrp3 channels. Nature. 1998;396:478-482.
58. Berg L-P, Shamsher MK, El-Daher SS, Kakkar VV, Authi KS. Expression of human TRPC genes the megakaryocytic cell lines MEG01, DAMI and HEL. FEBS Lett. 1997;403:83-86.
59. 2+ concentration in fura 2-loaded human platelets. J Biol Chem. 1987;262:16,364-16,369.
60. Somasundaram B, Mahaut-Smith MP. A monovalent cation channel activated by inositol trisphosphate in the plasma membrane of rat megakaryocytes. J Biol Chem. 1995;270:16,638-16,644.
61. Supattapone S, Danoff SK, Theibert A, Joseph S, Steiner J, Snyder SH. Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci U S A. 1988;85:8747-8750.
62. 2+ flux in reconstituted lipid vesicles. J Biol Chem. 1994;269:6735-6742.
63. Geiger J, Nolte C, Butt E, Sage SO, Walter U. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci U S A. 1992;89:1031-1035.
64. Geiger J, Nolte C, Walter U. Regulation of calcium mobilization and entry in human platelets by endothelium derived relaxing factors. Am J Physiol. 1994;267:C236-C244.
65. Watson SP, McConnel RT, Lapetina EG. The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. J Biol Chem. 1984;259:13,199-13,203.
66. 2+ uptake in human platelets by cAMP. Biochim Biophys Acta. 1992;1105:29-39.
67. 2+ extrusion from human platelets. Biochim Biophys Acta. 1992;1105:19-28.
68. Cavallini L, Coassin M, Borean A, Alexandre A. Prostacyclin and sodium nitroprusside inhibit the activation of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Cham. 1996;271:5545-5551.
69. 2+ release in a living cell. Proc Natl Acad Sci U S A. 1998;95: 1613-1617.
70. Wojcikiewicz RJH, Luo SG. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase: type I, II and III are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J Biol Chem. 1998; 273:5670-5677.
71. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem. 1994;269:8701-8707.